Clinical Trials
A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer (CTMS# 19-0019)
Cancer Type
Urothelial Tract/Bladder Cancer
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
John Sarantopoulos MD